Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2022 | Areas of unmet need for patients with NSCLC and brain metastases

Alessandra Bearz, MD, CRO National Cancer Institute, Aviano, Italy, describes current unmet needs for oncogene addicted patients with NSCLC and brain metastases, including elucidating the most effective therapies for first-line treatment as well as strategies to overcome resistance. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.